FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to psychiatry and can be used in the prevention and/or treatment of psychoactive substance dependence. The method includes gene genotyping of dopamine, serotonin, noradrenaline and gamma-aminobutyric acids of the neurotransmitter system, psychodiagnostic testing to form psychological types by polymorphisms in the specified genes. Then dietary supplements and/or pharmacotherapy are prescribed with considering the genotyping results and the identified psychological types with neurotransmitter imbalance.
EFFECT: use of the invention allows for higher clinical effectiveness ensured by the correction of neurotransmitter imbalance predisposing to dependence.
8 cl, 1 tbl, 7 ex
Authors
Dates
2010-11-10—Published
2008-12-26—Filed